Eversept Partners’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14M	Sell	713,269 -1,068,966	-60%	-$31.7M	0.92%	35
2025 Q4	$55.5M	Sell	1,782,235 -142,071	-7%	-$3.9M	3.11%	8
2025 Q3	$41.5M	Buy	1,924,306 +21,767	+1%	+$393K	3.18%	10
2025 Q2	$26.6M	Buy	1,902,539 +524,865	+38%	+$7.12M	2.68%	10
2025 Q1	$18.6M	Buy	1,377,674 +597,676	+77%	+$10.2M	2.1%	18
2024 Q4	$15M	Buy	779,998 +88,766	+13%	+$1.93M	1.54%	18
2024 Q3	$15.7M	Buy	691,232 +123,745	+22%	+$2.02M	1.21%	22
2024 Q2	$7.38M	Buy	567,487 +425,412	+299%	+$5.89M	0.57%	34
2024 Q1	$2.49M	Buy	142,075 +4,732	+3%	+$91.7K	0.19%	58
2023 Q4	$2.99M	Sell	137,343 -305,927	-69%	-$4.83M	0.29%	44
2023 Q3	$6.8M	Buy	+443,270	New	+$8.46M	0.75%	32
2022 Q4	–	Sell	-478,387	Closed	-$9.81M	–	84
2022 Q3	$9.81M	Buy	478,387 +32,795	+7%	+$590K	1.16%	26
2022 Q2	$5.16M	Buy	445,592 +289,849	+186%	+$3.9M	0.5%	47
2022 Q1	$2.88M	Sell	155,743 -38,846	-20%	-$746K	0.27%	54
2021 Q4	$3.85M	Buy	194,589 +34,589	+22%	+$644K	0.32%	66
2021 Q3	$2.63M	Buy	+160,000	New	+$2.35M	0.21%	67